刘静, 赵冬 (2009) Framingham心脏研究的过去、现在和将来. 中华心血管病杂志, 37, 470-471.
心血管疾病风险评估研究的概况Survey of the Risk Assessment of Cardiovascular Disease
李雪平, 谢艳虹, 许朝霞, 王忆勤
心血管病, 危险因素, 风险评估, 四诊信息Cardiovascular Disease, Risk Factor, Risk Assessment, Information from TCM Four Diagnostic Methods
《Advances in Clinical Medicine》, Vol.5 No.3, 2015-09-09
心血管疾病因其高发病率、高致死率，成为世界范围内最大的疾病负担。作者通过查阅国内外大量相关文献，比较目前常用的心血管病风险评估工具如Framingham风险评估、美国胆固醇教育计划成人治疗组第三次指南(NCEP ATP III)、欧洲系统性冠心病风险评估、英国QRISK心血管风险评估、Reynolds风险评分等，发现CVD风险评估模型随着风险因素的不断发现而不断完善，同时也存在不同程度的局限性。我国尚缺乏对CVD进行全面系统、综合传统风险因素和遗传因素的有效风险评估手段，进而提出将中医四诊信息客观参数运用到CVD风险因素评估中,以期为我国疾病风险评估研究提供新的思路。
Cardiovascular diseases become the biggest burden of disease worldwide because of its high inci-dence and mortality. By collecting a large number of related literatures and comparing the present commonly used cardiovascular disease risk assessment tools such as Framingham risk assessment, the United States cholesterol program adult treatment group report (NCEP ATP III), Systematic Coronary Risk Evaluation in Europe, the British QRISK cardiovascular risk algorithm, Reynolds Risk Score and so on, we find that CVD risk assessment models are continuously improved with more risk factor being found and also there are different degrees of limitations. As the effective and comprehensive risk assessment of CVD, which takes conventional risk factors and genetic factors into consideration, is not available in China, we thus put forward the new research thinking that combines traditional Chinese medical method, information from TCM Four diagnostic methods, with CVD risk assessment to study the risk assessment of disease in our country.